Free Trial

Integer (ITGR) Competitors

$121.24
-0.41 (-0.34%)
(As of 05/31/2024 ET)

ITGR vs. PODD, TFX, GMED, MASI, IART, ATEC, ATRC, OFIX, SRDX, and ANGO

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Insulet (PODD), Teleflex (TFX), Globus Medical (GMED), Masimo (MASI), Integra LifeSciences (IART), Alphatec (ATEC), AtriCure (ATRC), Orthofix Medical (OFIX), Surmodics (SRDX), and AngioDynamics (ANGO). These companies are all part of the "health care equipment" industry.

Integer vs.

Insulet (NASDAQ:PODD) and Integer (NYSE:ITGR) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings, risk and community ranking.

In the previous week, Insulet had 10 more articles in the media than Integer. MarketBeat recorded 14 mentions for Insulet and 4 mentions for Integer. Integer's average media sentiment score of 1.03 beat Insulet's score of 0.69 indicating that Insulet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Insulet
8 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Insulet has a net margin of 13.14% compared to Insulet's net margin of 6.01%. Integer's return on equity of 34.06% beat Insulet's return on equity.

Company Net Margins Return on Equity Return on Assets
Insulet13.14% 34.06% 9.08%
Integer 6.01%11.25%5.69%

Insulet has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, Integer has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.

Insulet presently has a consensus target price of $239.18, suggesting a potential upside of 34.98%. Integer has a consensus target price of $128.00, suggesting a potential upside of 5.58%. Given Integer's stronger consensus rating and higher probable upside, analysts clearly believe Insulet is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Insulet
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83
Integer
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Insulet received 337 more outperform votes than Integer when rated by MarketBeat users. Likewise, 66.08% of users gave Insulet an outperform vote while only 63.41% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
InsuletOutperform Votes
713
66.08%
Underperform Votes
366
33.92%
IntegerOutperform Votes
376
63.41%
Underperform Votes
217
36.59%

99.3% of Integer shares are owned by institutional investors. 0.5% of Insulet shares are owned by company insiders. Comparatively, 2.0% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Insulet has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Insulet$1.70B7.31$206.30M$3.3053.69
Integer$1.60B2.54$90.65M$2.8941.95

Summary

Insulet beats Integer on 15 of the 18 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$4.06B$3.21B$5.11B$17.81B
Dividend YieldN/A1.69%2.75%3.55%
P/E Ratio41.957.44120.3622.67
Price / Sales2.5473.972,428.4511.15
Price / Cash15.3268.9035.0418.95
Price / Book2.664.165.525.90
Net Income$90.65M$86.13M$105.88M$976.46M
7 Day Performance-1.13%-1.51%1.13%0.62%
1 Month Performance10.45%2.15%1.42%4.79%
1 Year Performance46.73%-9.15%4.04%24.00%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PODD
Insulet
4.9066 of 5 stars
$180.07
+5.4%
$239.44
+33.0%
-35.4%$12.61B$1.70B54.573,000Analyst Forecast
Insider Selling
Short Interest ↑
TFX
Teleflex
4.4128 of 5 stars
$206.35
-0.1%
$261.75
+26.8%
-10.9%$9.72B$2.97B33.1214,500Short Interest ↑
Analyst Revision
GMED
Globus Medical
4.7409 of 5 stars
$65.82
+0.7%
$68.50
+4.1%
+24.0%$8.91B$1.57B102.855,000Analyst Forecast
Short Interest ↓
Analyst Revision
Positive News
MASI
Masimo
4.7166 of 5 stars
$127.00
+1.8%
$138.71
+9.2%
-23.1%$6.74B$1.98B86.395,200Short Interest ↓
Analyst Revision
Positive News
IART
Integra LifeSciences
4.7726 of 5 stars
$28.31
-0.7%
$35.00
+23.6%
-18.6%$2.23B$1.54B56.623,946Positive News
Gap Up
ATEC
Alphatec
4.5266 of 5 stars
$10.12
+0.2%
$22.89
+126.2%
-35.9%$1.42B$482.26M-6.79839Short Interest ↓
Positive News
ATRC
AtriCure
2.82 of 5 stars
$23.19
+3.3%
$49.78
+114.7%
-49.9%$1.10B$414.60M-28.991,200Insider Buying
News Coverage
Positive News
OFIX
Orthofix Medical
1.0617 of 5 stars
$14.89
+0.1%
$18.00
+20.9%
-26.5%$558.82M$746.64M-4.411,634
SRDX
Surmodics
3.0749 of 5 stars
$34.38
+0.5%
$57.00
+65.8%
+129.5%$490.26M$132.58M36.19376Analyst Forecast
Analyst Revision
News Coverage
ANGO
AngioDynamics
4.537 of 5 stars
$6.17
+0.8%
$13.25
+114.7%
-33.3%$247.17M$338.75M-1.27815Short Interest ↓
Analyst Revision
News Coverage

Related Companies and Tools

This page (NYSE:ITGR) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners